231 related articles for article (PubMed ID: 18646607)
1. [Detection of minimal residual disease in leukemia using flow cytometry].
Muroi K
Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
[No Abstract] [Full Text] [Related]
2. A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
Capolunghi F; Capponi C; De Stefani B; Luciani M; Locatelli F; Muraca M; Carsetti R
Am J Hematol; 2014 Mar; 89(3):343-4. PubMed ID: 24265183
[No Abstract] [Full Text] [Related]
3. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
5. Monitoring minimal residual disease in pediatric hematologic malignancies.
Campana D
Clin Adv Hematol Oncol; 2007 Nov; 5(11):876-7, 915. PubMed ID: 18185484
[No Abstract] [Full Text] [Related]
6. Minimal residual disease detection by flow cytometry.
Ludwig WD
Lab Hematol; 2004; 10(3):169. PubMed ID: 15529435
[No Abstract] [Full Text] [Related]
7. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
Digiuseppe JA
Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
[TBL] [Abstract][Full Text] [Related]
8. The detection and significance of minimal residual disease in acute and chronic leukemia.
Chung NG; Buxhofer-Ausch V; Radich JP
Tissue Antigens; 2006 Nov; 68(5):371-85. PubMed ID: 17092250
[TBL] [Abstract][Full Text] [Related]
9. NRP-1/CD304 expression in acute leukemia: a potential marker for minimal residual disease detection in precursor B-cell acute lymphoblastic leukemia.
Meyerson HJ; Blidaru G; Edinger A; Osei E; Schweitzer K; Fu P; Ho L
Am J Clin Pathol; 2012 Jan; 137(1):39-50. PubMed ID: 22180477
[TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
[TBL] [Abstract][Full Text] [Related]
11. The use of flow cytometry to detect minimal residual disease in acute leukemia.
Campana D; Coustan-Smith E
Eur J Histochem; 1996; 40 Suppl 1():39-42. PubMed ID: 8839698
[No Abstract] [Full Text] [Related]
12. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.
Muzzafar T; Medeiros LJ; Wang SA; Brahmandam A; Thomas DA; Jorgensen JL
Am J Clin Pathol; 2009 Nov; 132(5):692-8. PubMed ID: 19846809
[TBL] [Abstract][Full Text] [Related]
13. Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia.
Krampera M; Perbellini O; Maggioni A; Scognamiglio F; Todeschini G; Pizzolo G
Haematologica; 2001 Mar; 86(3):322-3. PubMed ID: 11255283
[No Abstract] [Full Text] [Related]
14. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
Mlcáková A; Babusíková O
Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
[TBL] [Abstract][Full Text] [Related]
15. Methodological approach to minimal residual disease detection by flow cytometry in adult B-lineage acute lymphoblastic leukemia.
Krampera M; Perbellini O; Vincenzi C; Zampieri F; Pasini A; Scupoli MT; Guarini A; De Propris MS; Coustan-Smith E; Campana D; Foà R; Pizzolo G
Haematologica; 2006 Aug; 91(8):1109-12. PubMed ID: 16885052
[TBL] [Abstract][Full Text] [Related]
16. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
Al-Mawali A; Gillis D; Hissaria P; Lewis I
Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.
Lioznov M; Badbaran A; Fehse B; Bacher U; Zander AR; Kröger NM
Bone Marrow Transplant; 2008 May; 41(10):913-6. PubMed ID: 18264143
[No Abstract] [Full Text] [Related]
18. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].
Tousková M; Maisnar V; Krejsek J; Kopecký O
Vnitr Lek; 1999 Dec; 45(12):708-12. PubMed ID: 10951845
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric monitoring of residual disease in acute leukemia.
Wood BL
Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]